In a landmark study that bridges the gap between mechanical movement and molecular biology, a research team from the Department…
Read More
J&J Positions Spravato Remission Data at Forefront of Treatment-Resistant Depression Growth Strategy
Johnson & Johnson (J&J) is intensifying its marketing efforts for Spravato (esketamine) by spotlighting compelling remission rate data for treatment-resistant…
Read More
Discovery of Fam102a Protein as a Dual Regulator of Bone Remodeling Offers New Pathways for Osteoporosis Treatment
In a landmark study that could redefine the clinical approach to metabolic bone diseases, a team of researchers led by…
Read More
Yale Researchers Decipher Molecular Mechanism Blocking Fertilization Opening New Frontiers for Infertility Treatment and Contraception
A multidisciplinary research team led by Yale University has achieved a significant breakthrough in reproductive biology by mapping the precise…
Read More
HKUMed Researchers Identify Piezo1 Protein as Bone Exercise Sensor Opening New Frontiers for Osteoporosis Treatment and Exercise Mimetics
Researchers from the Department of Medicine at the School of Clinical Medicine, LKS Faculty of Medicine, University of Hong Kong…
Read More
ADA Conference Highlights: GLP-1 Innovations Reshape Metabolic Treatment Landscape Amidst Unprecedented Scientific Advocacy Protest
The annual scientific sessions of the American Diabetes Association (ADA) this week served as a dual-faceted arena, showcasing both groundbreaking…
Read More
J&J Poster Puts Spravato Remission Data at Center of Treatment-Resistant Depression Growth Push
More than six decades after Calvin Stevens first synthesized ketamine at Parke-Davis in 1962 while diligently searching for a safer…
Read More
Beyond PD-1: The Drugs Reshaping Cancer Treatment at ASCO 2026
The biotech sector is experiencing a robust resurgence, marked by significant investment, strategic mergers and acquisitions, and groundbreaking clinical advancements,…
Read More
Glioblastoma Research Reveals Skull Erosion and Immune System Reprogramming Reshaping Treatment Strategies
The medical community has long viewed glioblastoma multiforme (GBM) as a localized, albeit highly aggressive, malignancy confined within the blood-brain…
Read More
J&J Poster Puts Spravato Remission Data at Center of Treatment-Resistant Depression Growth Push
More than six decades after Calvin Stevens first synthesized ketamine at Parke-Davis in a quest for a safer anesthetic, the…
Read MoreYOU MAY HAVE MISSED
